Sales +16% y-o-y, +1% vs. ABGSCe Strong order momentum (+78% y-o-y, +8% vs.
In July 2022, OrderYOYO completed the merger with app smart, which has created a twice as large comp...
Sales +3% and EBITDA +9% vs. cons, respectively Expect cons to raise EBITDA estimates by 3-4% Confer...
VEF continues to trade below pre-covid levels at a 40% discount to reported NAV (58% to our estimate...
Consti's net sales in Q3 amounted to EUR 79.0m, in line with our and consensus estimates (EUR 79.
SRV's net sales in Q3 amounted to EUR 186.8m, above our estimates and below consensus (EUR 176.
CapMan's net sales in Q3 amounted to EUR 15.9m, below our estimates and below consensus (EUR 19.
Scanfil’s Q3 results were largely as expected. Demand remains strong and EBIT should continue to inc...
Solteq’s Q3 was below the already weak expectations, with revenue at EUR 14.
Redeye gives an initial take on Alelion’s Q3 figures, which was largely in line with our expectation...
A step in the right direction Performance Chemicals returned to growth in Q3 and beat our sales esti...
Redeye believes that Sdiptech’s Q3 report was in line with our expectations.
Redeye leaves its initial take on Stille's report for the third quarter of 2022, containing both pos...
Redeye will lower its estimates slightly on the back of this Q3 2022 report, which missed expectatio...
XVIVO delivers a Q3 with 35% organic (CER) growth which is booth solid and ahead of our expectations...
Redeye states that the Q3 report was considerably weaker than expected on both top line and bottom l...
Redeye states that the Q3 report was mixed, with higher profitability than expected but lower-than-e...
Q3 trading update released this morning (the company reports semi-annually, no quarterly consensus a...
CapMan reported Q3 EBIT of 12.7m, 7% above Refinitiv consensus.
Redeye makes slight forecast adjustments following Hoylu’s Q3 2022 report.
